Xxera/openscience/retractions

Record #55299

Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung

Zizong Wang, Yunpeng Xuan, Yanmei Shao, Qiang Zou, Hong Cui, Xiangfeng Jin

Journal

Computational Intelligence and Neuroscience

Publisher

Original paper date

Nov 18, 2022

Original DOI

10.1155/2022/3137370

Country

Institution

Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, China · Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266000, China · Department of Blood Transfusio, The Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao 266000, China · Operation Room, The Affiliated Hospital of Qingdao University, Qingdao 266003, China

Open access

No

Article type

Broad categories

(HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Notes from Retraction Watch

See also: https://pubpeer.com/publications/692C7BD08AC6CA7ABA566B76AF012B

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

1

Post-retraction

0

% post-retraction

0.0%

~0.0 citations/yr before retraction · ~0.0 citations/yr after

— citing papers

Who is still citing this work

Loading…